| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73361 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74260 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74442 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73361 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74260 | |||
![Western Blot: PGD Antibody (OTI2A5) [NBP2-45880] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PGD.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Western-Blot-NBP2-45880-img0010.jpg "Western Blot: PGD Antibody (OTI2A5) [NBP2-45880] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PGD.")
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human thyroid tissue using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0009.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human pancreas tissue within the normal limits using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0002.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Carcinoma of Human prostate tissue using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0003.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human prostate tissue within the normal limits using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0004.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human ovary tissue using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0005.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human breast tissue within the normal limits using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0006.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human Kidney tissue within the normal limits using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0007.jpg)
![Immunohistochemistry-Paraffin: PGD Antibody (OTI2A5) [NBP2-45880] - Human endometrium tissue using anti-PGD mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100 degrees C for 10min.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunohistochemistry-NBP2-45880-img0008.jpg)
![Immunofluorescence: PGD Antibody (OTI2A5) [NBP2-45880] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY PGD.](http://images.novusbio.com/fullsize/PGD-Antibody-OTI2A5-Immunofluorescence-NBP2-45880-img0001.jpg)
![Western Blot: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SNRPB2.](http://images.novusbio.com/fullsize/SNRPB2-Antibody-2A5-Western-Blot-NBP2-45893-img0005.jpg "Western Blot: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SNRPB2.")
![Immunohistochemistry: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SNRPB2-Antibody-2A5-Immunohistochemistry-NBP2-45893-img0004.jpg)
![Immunohistochemistry: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SNRPB2-Antibody-2A5-Immunohistochemistry-NBP2-45893-img0001.jpg)
![Immunohistochemistry: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SNRPB2-Antibody-2A5-Immunohistochemistry-NBP2-45893-img0002.jpg)
![Immunohistochemistry: SNRPB2 Antibody (2A5) [NBP2-45893] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/SNRPB2-Antibody-2A5-Immunohistochemistry-NBP2-45893-img0003.jpg)
![Western Blot: TAF2 Antibody (OTI2A5) [NBP2-01967] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TAF2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TAF2.](http://images.novusbio.com/fullsize/TAF2-Antibody-2A5-Western-Blot-NBP2-01967-img0001.jpg "Western Blot: TAF2 Antibody (OTI2A5) [NBP2-01967] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TAF2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TAF2.")